Gail Cawkwell - Jun 27, 2022 Form 3 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
ACRS
Transactions as of
Jun 27, 2022
Transactions value $
$0
Form type
3
Date filed
7/5/2022, 04:54 PM
Previous filing
Feb 15, 2022
Next filing
Jul 5, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24.1 - Power of Attorney